THE INDIAN PHARMACIST Official Circular Pharmacy LogoTHE INDIAN PHARMACISTLearn. Explore. Practise. Excel.
EDITION 2.7 MONOGRAPH [9.4] • ID: TIP-MED-000168

Salmeterol Xinafoate (in Fixed-Dose Combination with Fluticasone Propionate)

Slow-Onset Long-Acting Beta-2 Adrenergic Agonist (LABA; 12-Hour Bronchodilator with Slow 15–30 Minute Onset) • Schedule H Prescription Drug (To be sold by retail on the prescription of a Registered Medical Practitioner only β€” Drugs Rules 1945)

βš–οΈ Compare with Another Medicine

Level 1 β€” Quick Professional Summary (At a Glance)

1. Generic Name & Identifier:
Salmeterol Xinafoate (in Fixed-Dose Combination with Fluticasone Propionate)
Monograph Code: [9.4] | Stable ID: TIP-MED-000168
2. Verified Indian Market Brands:
Seroflo (Cipla), Foracort (Cipla)
3. Pharmacological & Therapeutic Class:
Slow-Onset Long-Acting Beta-2 Adrenergic Agonist (LABA; 12-Hour Bronchodilator with Slow 15–30 Minute Onset)
Respiratory, Asthma, COPD & Allergy Medicines (Ch 09)
4. Dosage Forms, Strengths & Route:
Seroflo pMDI Inhaler: Salmeterol 25 mcg + Fluticasone Propionate 125 mcg or 250 mcg per puff; Seroflo Rotacaps / Autohaler / Accuhaler (DPI): Salmeterol 50 mcg + Fluticasone Propionate 100 mcg, 250 mcg, or 500 mcg; Seroflo pMDI Inhaler: Salmeterol 25 mcg + Fluticasone Propionate 125 mcg or 250 mcg per puff; Seroflo Rotacaps / Autohaler / Accuhaler (DPI): Salmeterol 50 mcg + Fluticasone Propionate 100 mcg, 250 mcg, or 500 mcg; Seroflo pMDI Inhaler: Salmeterol 25 mcg + Fluticasone Propionate 125 mcg or 250 mcg per puff; Seroflo Rotacaps / Autohaler / Accuhaler (DPI): Salmeterol 50 mcg + Fluticasone Propionate 100 mcg, 250 mcg, or 500 mcg
Route: Oral / Parenteral / Topical as specified by formulation

9–10. Mechanism of Action & Pharmacodynamics

Slow-Onset Long-Acting Beta-2 Adrenergic Agonist (LABA; 12-Hour Bronchodilator with Slow 15–30 Minute Onset) acting on target receptor/enzyme pathways in Respiratory, Asthma, COPD & Allergy Medicines (Ch 09): clinical efficacy is mediated via Slow-Onset Long-Acting Beta-2 Adrenergic Agonist (LABA; 12-Hour Bronchodilator with Slow 15–30 Minute Onset) for Regular maintenance controller therapy for persistent Bronchial Asthma and severe COPD with history of repeated exacerbations..

12. Therapeutic Indications

13 & 16. Contraindications, Precautions & Warnings

🚫 Contraindications:
  • CRITICAL DIFFERENCE FROM FORMOTEROL (FORACORT): Salmeterol has a SLOW onset of action (takes 15 to 30 minutes to begin opening airways, peaking at 2–3 hours)! Therefore, Seroflo MUST NEVER BE USED AS AN ACUTE RESCUE RELIEVER during a sudden asthma attack! Patients using Seroflo MUST always carry a separate fast-acting reliever inhaler (such as Salbutamol [Asthalin]) for sudden breathlessness! Never exceed twice-daily dosing.
⚠️ Precautions & Warnings:

Renal: No dose adjustment needed. Hepatic: Both salmeterol and fluticasone undergo extensive hepatic CYP3A4 clearance; monitor closely in moderate-to-severe liver disease.

14. Dosage & Administration Context (Educational Reference Summary)

Dosing & Indication Context: General Adult Reference: pMDI: 2 puffs twice daily (every 12 hours, delivering 50 mcg salmeterol/dose). Rotacap / Accuhaler DPI: 1 capsule/blister (50 mcg salmeterol) twice daily (every 12 hours). Maximum dose: 50 mcg Salmeterol twice daily! Follow physician prescription.
Administration & Timing: Inhaled: Independent of food; rinse mouth and spit after every dose. | Strictly twice daily (every 12 hours: morning and night).

Level 2 β€” Detailed Pharmacology, PK, Interactions & Special Populations

11 & 19. Pharmacokinetics (ADME), Renal & Hepatic Considerations

Pharmacokinetic Profile: Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.

Renal Considerations: Renal: No dose adjustment needed. Hepatic: Both salmeterol and fluticasone undergo extensive hepatic CYP3A4 clearance; monitor closely in moderate-to-severe liver disease.

Hepatic Considerations: Renal: No dose adjustment needed. Hepatic: Both salmeterol and fluticasone undergo extensive hepatic CYP3A4 clearance; monitor closely in moderate-to-severe liver disease.

15 & 17. Adverse Effects & Clinically Significant Drug Interactions
Adverse Effects:
  • Oropharyngeal candidiasis (thrush) and hoarseness of voice (fluticasone has high topical potency and throat deposition if a spacer and mouth rinse are not used), fine tremor, palpitations, headache, muscle cramps.
  • Increased incidence of bacterial Pneumonia in elderly COPD patients (particularly with the high 500 mcg fluticasone strength), systemic steroid effects (adrenal suppression, cataracts, osteoporosis), hypokalaemia, arrhythmias in IHD patients, paradoxical bronchospasm.
Major Drug Interactions:
  • Potent CYP3A4 Inhibitors (Ritonavir, Ketoconazole, Itraconazole, Clarithromycin): STRICTLY AVOID! Ritonavir and itraconazole increase plasma Fluticasone levels >100-fold (causing severe Cushing's syndrome and adrenal crisis) and increase Salmeterol levels (causing QTc prolongation and ventricular arrhythmias)
  • Non-selective beta-blockers antagonise salmeterol
  • Diuretics/theophylline increase hypokalaemia
18, 20, 21 & 22. Special Populations, Monitoring, Counselling & Storage

Pregnancy, Lactation, Paediatric & Geriatric Use: Evaluate maternal-foetal benefit-risk ratio and age-appropriate organ function before prescribing.

Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.

Patient Counselling Points:
  • Patient Counselling Checklist: 1. Warn every patient on Seroflo: 'Seroflo is your slow-acting 12-hour daily shieldβ€”it takes 20 minutes to start working, so NEVER puff extra Seroflo during a sudden breathless attack! Keep your blue Asthalin inhaler handy for sudden rescue.' 2. Note that pMDI requires 2 puffs to deliver 50 mcg salmeterol (with a 30–60 second pause between puff 1 and puff 2), whereas Rotacaps require 1 capsule inside the Rotahaler. 3. Always rinse mouth, gargle, and spit water after every use!
  • Meal & Clock Timing Instruction: Inhaled: Independent of food; rinse mouth and spit after every dose. (Strictly twice daily (every 12 hours: morning and night).)
  • Missed Dose Protocol: Take the next scheduled dose at the normal time; never take extra puffs of Seroflo for acute breathlessness.
  • Geriatric Dispensing Pearl: In elderly COPD patients using high-strength Seroflo 250 or 500, watch closely for recurrent lower respiratory infections/pneumonia, oral thrush, cataracts, and easy skin bruising; verify if the chest physician can step down steroid dose or use LAMA/LABA dual bronchodilation if eosinophils are low.

Storage & Dispensing Governance: Store below 25Β°C–30Β°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Seroflo pMDI Inhaler: Salmeterol 25 mcg + Fluticasone Propionate 125 mcg or 250 mcg per puff; Seroflo Rotacaps / Autohaler / Accuhaler (DPI): Salmeterol 50 mcg + Fluticasone Propionate 100 mcg, 250 mcg, or 500 mcg

Visual Pharmacology Mechanism Diagram (PLATE-8.7)

ROUTE-SPECIFIC DRUG DELIVERY: ONSET, BIOAVAILABILITY (F) & FIRST-PASS BYPASS 1. Oral (PO) β€’ Onset: 30–90 min β€’ F: Variable (5–99%) β€’ First-Pass: YES (High) Safest, convenient; requires dissolution & portal transit. 2. Sublingual (SL) β€’ Onset: 1–3 min (Rapid) β€’ Drains to SVC directly β€’ First-Pass: BYPASSED e.g. Sublingual GTN 0.5 mg in acute angina pectoris. 3. Buccal Route β€’ Onset: 3–10 min β€’ Cheek pouch mucosa β€’ First-Pass: BYPASSED e.g. Buccal Midazolam, Buprenorphine, Fentanyl. 4. Intravenous (IV) β€’ Onset: 15–60 sec β€’ Bioavailability F = 100% β€’ First-Pass: BYPASSED Strict asepsis & tonicity; irreversible once injected. 5. Intramuscular (IM) β€’ Onset: 10–20 min β€’ F: 75–100% β€’ First-Pass: BYPASSED Deltoid / Vastus lateralis; oily depot formulations. 6. Subcutaneous (SC) β€’ Onset: 15–30 min β€’ Slow sustained absorption β€’ First-Pass: BYPASSED Insulins, Enoxaparin (LMWH); rotate injection sites. 7. Inhalational β€’ Onset: 2–5 min β€’ Particle size 1–5 μm β€’ Targeted Pulmonary Salbutamol, ICS; rinse mouth after ICS to prevent thrush. 8. Transdermal Patch β€’ Onset: Hours (Steady) β€’ Stratum corneum barrier β€’ First-Pass: BYPASSED Fentanyl, GTN, Nicotine, Rivastigmine patches. 9. Topical / Ophthalmic β€’ Local skin/mucosal effect β€’ Minimal systemic toxicity β€’ Nasolacrimal occlusion Timolol eye drops bypass first-pass if absorbed systemically. 10. Rectal (PR) β€’ Onset: 5–30 min β€’ Useful in vomiting/seizure β€’ ~50% First-Pass Bypass Rectal Diazepam in paediatric febrile status epilepticus.
Figure 8.7: Comparative biopharmaceutics across 10 routes of administration: Oral, Sublingual, Buccal, Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Inhalational, Transdermal, Topical, and Rectal.

23. Traceable Source References & Jurisdiction

Primary Reference Record: Indian Pharmacist Desk Reference β€” Professional Edition 2.7 (2026–27) β€’ Ch 09 [9.4] (p. 115)

Authoritative Verification Portals: Indian Pharmacopoeia Commission (IPC) • CDSCO (India Jurisdiction) • NCBI Bookshelf • DailyMed (US FDA Label Reference)

Last Checked Date: 2026-11-08 • Related Study Guide: Bronchial Asthma & COPD Stepwise Inhaler Guide →